Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AAAAI, Aaron, abnormal, absolute, Academy, addendum, AFFY, AGEN, Allergy, allosteric, alpelisib, ALT, Antonio, APGE, Apogee, ascending, Asthma, Atkinson, Averill, azacitadine, bad, Barr, behavior, biliary, BioPharm, BlackRock, BMY, breakdown, breast, Bryant, Carlo, catch, category, CCPA, center, CEO, Charleston, chemotype, Chen, Cohen, coincide, Colby, column, Commodore, Compensia, compromise, concomitant, Conshohocken, constantly, Counsel, CPRA, crossed, crossing, Crossover, Cubist, culture, cyber, cybersecurity, cycle, cysteine, cytosol, DCR, dedicated, deployment, designee, devote, Diary, EGC, Egen, Elm, enzymatic, EPZM, equipotent, Evan, evergreen, exceeded, excellence, exemplar, Exploratory, extortion, FDORA, Feb, fluctuate, FMR, Fore, forfeiture, Goodwin, graph, hardware, HCM, highest, honesty, Hudson, HUTCHMED, hypersensitivity, hypothetical, IDTA, immature, Immunology, Impression, impressive, inadvertent, Indiana, inflationary, instability, insulin, intracranial, ion, IRA, Jersey, JNJ, kinome, Kramarz, Kynam, KZIA, leakage, leverage, licensure, lifetime, Likewise, literate, LNTH, Madison, malfunction, malware, maturity, mediator, mice, Michael, mirror, mobile, Monte, mouse, namomolar, narrative, NCI, nM, Nordisk, Nova, OLE, oncologist, onsite, outflow, oversee, page, pAKT, Paragon, path, PD, percentile, peripheral, PFE, PGIC, PHI, philosophy, phosphoinositide, PK, plasma, plc, Pool, Princeton, pro, Proctor, PROM, promptly, prospect, PSU, PwC, ransomware, regular, reinvestment, remitted, resale, residing, Road, Robert, SAE, score, scored, shutdown, simulation, slowdown, SNDX, SNY, software, Spyre, stable, Stephen, stretch, stringent, sudden, suggesting, Summer, Suvretta, Symposium, symptom, symptomatic, sympton, SYRE, Systematic, TAK, Tang, TC, TCBP, TCG, TGI, theft, Thirty, TKAI, Toledo, tool, tracing, tranche, TSS, tucatinib, unethical, VAF, VeraSafe, vi, week, West, workflow, writer, WT, Wyman, Yu, Yue, YVMA
Removed:
adaptive, advancement, attestation, Automation, billion, BOXR, Celldex, Century, chimeric, correspondingly, depression, disrupted, drafted, earliest, exemption, expressing, fine, fluidity, golden, hour, Industrial, invoicing, irrevocably, Jumpstart, legacy, lessee, NIH, nonconvertible, outbreak, parachute, platform, prediction, provisionally, qualifying, raw, refundable, returning, routinely, run, situation, stipulated, sublessee, tenant, Trademark, transposed, unaudited, viewpoint, Xencor
Filing tables
Filing exhibits
Related press release
COGT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-273802, 333-270522, 333-263638, 333-258865, 333-254320, 333-249884, 333-224137, 333-237406 and 333-230559) and Form S-3 (Nos. 333-269707, 333-264773, and 333-248971) of Cogent Biosciences, Inc. of our report dated February 26, 2024 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 26, 2024